These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23917155)

  • 1. Atmospheric transport modelling of time resolved 133Xe emissions from the isotope production facility ANSTO, Australia.
    Schöppner M; Plastino W; Hermanspahn N; Hoffmann E; Kalinowski M; Orr B; Tinker R
    J Environ Radioact; 2013 Dec; 126():1-7. PubMed ID: 23917155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Setting the baseline for estimated background observations at IMS systems of four radioxenon isotopes in 2014.
    Gueibe C; Kalinowski MB; Baré J; Gheddou A; Krysta M; Kusmierczyk-Michulec J
    J Environ Radioact; 2017 Nov; 178-179():297-314. PubMed ID: 28942373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimates of radioxenon released from Southern Hemisphere medical isotope production facilities using measured air concentrations and atmospheric transport modeling.
    Eslinger PW; Friese JI; Lowrey JD; McIntyre JI; Miley HS; Schrom BT
    J Environ Radioact; 2014 Sep; 135():94-9. PubMed ID: 24811887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International challenge to predict the impact of radioxenon releases from medical isotope production on a comprehensive nuclear test ban treaty sampling station.
    Eslinger PW; Bowyer TW; Achim P; Chai T; Deconninck B; Freeman K; Generoso S; Hayes P; Heidmann V; Hoffman I; Kijima Y; Krysta M; Malo A; Maurer C; Ngan F; Robins P; Ross JO; Saunier O; Schlosser C; Schöppner M; Schrom BT; Seibert P; Stein AF; Ungar K; Yi J
    J Environ Radioact; 2016 Jun; 157():41-51. PubMed ID: 26998569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence on the radioxenon background during the temporary suspension of operations of three major medical isotope production facilities in the Northern Hemisphere and during the start-up of another facility in the Southern Hemisphere.
    Saey PR; Auer M; Becker A; Hoffmann E; Nikkinen M; Ringbom A; Tinker R; Schlosser C; Sonck M
    J Environ Radioact; 2010 Sep; 101(9):730-8. PubMed ID: 20554098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of radioxenon releases in Australia using atmospheric dispersion modelling tools.
    Tinker R; Orr B; Grzechnik M; Hoffmann E; Saey P; Solomon S
    J Environ Radioact; 2010 May; 101(5):353-61. PubMed ID: 20346548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of radioxenon in Darwin, Australia following the Fukushima Dai-ichi nuclear power plant accident.
    Orr B; Schöppner M; Tinker R; Plastino W
    J Environ Radioact; 2013 Dec; 126():40-4. PubMed ID: 23933085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time resolution requirements for civilian radioxenon emission data for the CTBT verification regime.
    De Meutter P; Camps J; Delcloo A; Deconninck B; Termonia P
    J Environ Radioact; 2018 Feb; 182():117-127. PubMed ID: 29223860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the capability to model the background and its uncertainty of CTBT-relevant radioxenon isotopes in Europe by using ensemble dispersion modeling.
    De Meutter P; Camps J; Delcloo A; Deconninck B; Termonia P
    J Environ Radioact; 2016 Nov; 164():280-290. PubMed ID: 27532672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncertainty quantification of atmospheric transport and dispersion modelling using ensembles for CTBT verification applications.
    De Meutter P; Delcloo AW
    J Environ Radioact; 2022 Sep; 250():106918. PubMed ID: 35653875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International challenge to model the long-range transport of radioxenon released from medical isotope production to six Comprehensive Nuclear-Test-Ban Treaty monitoring stations.
    Maurer C; Baré J; Kusmierczyk-Michulec J; Crawford A; Eslinger PW; Seibert P; Orr B; Philipp A; Ross O; Generoso S; Achim P; Schoeppner M; Malo A; Ringbom A; Saunier O; Quèlo D; Mathieu A; Kijima Y; Stein A; Chai T; Ngan F; Leadbetter SJ; De Meutter P; Delcloo A; Britton R; Davies A; Glascoe LG; Lucas DD; Simpson MD; Vogt P; Kalinowski M; Bowyer TW
    J Environ Radioact; 2018 Dec; 192():667-686. PubMed ID: 29525108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of radiopharmaceutical isotope production on the global radioxenon background.
    Saey PR
    J Environ Radioact; 2009 May; 100(5):396-406. PubMed ID: 19233525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of Xe-133 background at the IMS stations in the East Asian region: Insights based on known sources and atmospheric transport modelling.
    Kuśmierczyk-Michulec J; Baré J; Kalinowski M; Tipka A
    J Environ Radioact; 2022 Dec; 255():107033. PubMed ID: 36252400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isotopic noble gas signatures released from medical isotope production facilities--simulations and measurements.
    Saey PR; Bowyer TW; Ringbom A
    Appl Radiat Isot; 2010 Sep; 68(9):1846-54. PubMed ID: 20447828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioxenon spiked air.
    Watrous MG; Delmore JE; Hague RK; Houghton TP; Jenson DD; Mann NR
    J Environ Radioact; 2015 Dec; 150():126-31. PubMed ID: 26318775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection in subsurface air of radioxenon released from medical isotope production.
    Johnson C; Biegalski S; Haas D; Lowrey J; Bowyer T; Hayes J; Suarez R; Ripplinger M
    J Environ Radioact; 2017 Feb; 167():160-165. PubMed ID: 27843063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global radioxenon emission inventory based on nuclear power reactor reports.
    Kalinowski MB; Tuma MP
    J Environ Radioact; 2009 Jan; 100(1):58-70. PubMed ID: 19070405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The workshop on signatures of medical and industrial isotope production - WOSMIP; Strassoldo, Italy, 1-3 July 2009.
    Matthews KM; Bowyer TW; Saey PR; Payne RF
    J Environ Radioact; 2012 Aug; 110():1-6. PubMed ID: 22307052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Source term estimates of radioxenon released from the BaTek medical isotope production facility using external measured air concentrations.
    Eslinger PW; Cameron IM; Dumais JR; Imardjoko Y; Marsoem P; McIntyre JI; Miley HS; Stoehlker U; Widodo S; Woods VT
    J Environ Radioact; 2015 Oct; 148():10-5. PubMed ID: 26093852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intercomparison experiments of systems for the measurement of xenon radionuclides in the atmosphere.
    Auer M; Axelsson A; Blanchard X; Bowyer TW; Brachet G; Bulowski I; Dubasov Y; Elmgren K; Fontaine JP; Harms W; Hayes JC; Heimbigner TR; McIntyre JI; Panisko ME; Popov Y; Ringbom A; Sartorius H; Schmid S; Schulze J; Schlosser C; Taffary T; Weiss W; Wernsperger B
    Appl Radiat Isot; 2004 Jun; 60(6):863-77. PubMed ID: 15110352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.